Morgan Stanley’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$75M Sell
247,962
-136,866
-36% -$41.4M ﹤0.01% 1557
2025
Q1
$127M Buy
384,828
+166,347
+76% +$55.1M 0.01% 1084
2024
Q4
$67.4M Sell
218,481
-50,913
-19% -$15.7M ﹤0.01% 1571
2024
Q3
$57.2M Buy
269,394
+49,363
+22% +$10.5M ﹤0.01% 1704
2024
Q2
$61.6M Sell
220,031
-68,575
-24% -$19.2M ﹤0.01% 1558
2024
Q1
$77.1M Sell
288,606
-15,230
-5% -$4.07M 0.01% 1371
2023
Q4
$70.3M Buy
303,836
+132,063
+77% +$30.6M ﹤0.01% 2083
2023
Q3
$25.1M Buy
171,773
+97,480
+131% +$14.2M ﹤0.01% 2217
2023
Q2
$17.2M Sell
74,293
-73,486
-50% -$17M ﹤0.01% 2632
2023
Q1
$35.8M Buy
147,779
+38,359
+35% +$9.29M ﹤0.01% 1861
2022
Q4
$31.8M Buy
109,420
+50,356
+85% +$14.6M ﹤0.01% 1906
2022
Q3
$3.84M Sell
59,064
-23,889
-29% -$1.55M ﹤0.01% 3907
2022
Q2
$5.94M Sell
82,953
-15,071
-15% -$1.08M ﹤0.01% 3603
2022
Q1
$9.62M Buy
98,024
+49,686
+103% +$4.87M ﹤0.01% 2946
2021
Q4
$4.1M Sell
48,338
-19,830
-29% -$1.68M ﹤0.01% 3921
2021
Q3
$5.44M Sell
68,168
-25,509
-27% -$2.03M ﹤0.01% 3597
2021
Q2
$9.13M Sell
93,677
-169,221
-64% -$16.5M ﹤0.01% 3097
2021
Q1
$30.8M Buy
262,898
+211,311
+410% +$24.7M ﹤0.01% 1545
2020
Q4
$5.73M Buy
51,587
+23,527
+84% +$2.62M ﹤0.01% 3104
2020
Q3
$3.33M Buy
28,060
+1,406
+5% +$167K ﹤0.01% 3133
2020
Q2
$3.02M Buy
26,654
+1,880
+8% +$213K ﹤0.01% 3188
2020
Q1
$1.65M Buy
24,774
+1,110
+5% +$74.1K ﹤0.01% 3526
2019
Q4
$2.16M Sell
23,664
-11,319
-32% -$1.03M ﹤0.01% 3977
2019
Q3
$3.02M Buy
34,983
+20,479
+141% +$1.77M ﹤0.01% 3412
2019
Q2
$1.52M Buy
14,504
+1,064
+8% +$112K ﹤0.01% 3986
2019
Q1
$1.68M Sell
13,440
-50,539
-79% -$6.33M ﹤0.01% 3728
2018
Q4
$7.21M Buy
63,979
+42,296
+195% +$4.77M ﹤0.01% 2477
2018
Q3
$4.64M Sell
21,683
-2,089
-9% -$447K ﹤0.01% 3263
2018
Q2
$6.65M Buy
23,772
+11,472
+93% +$3.21M ﹤0.01% 2828
2018
Q1
$1.44M Buy
12,300
+2,183
+22% +$255K ﹤0.01% 4282
2017
Q4
$928K Buy
10,117
+4,471
+79% +$410K ﹤0.01% 4593
2017
Q3
$255K Buy
5,646
+1,718
+44% +$77.6K ﹤0.01% 5230
2017
Q2
$63K Buy
3,928
+1,756
+81% +$28.2K ﹤0.01% 5793
2017
Q1
$33K Buy
2,172
+1,840
+554% +$28K ﹤0.01% 5949
2016
Q4
$5K Buy
332
+82
+33% +$1.24K ﹤0.01% 6275
2016
Q3
$3K Sell
250
-2
-0.8% -$24 ﹤0.01% 6323
2016
Q2
$3K Sell
252
-79
-24% -$940 ﹤0.01% 6303
2016
Q1
$3K Sell
331
-763
-70% -$6.92K ﹤0.01% 6359
2015
Q4
$14K Sell
1,094
-134
-11% -$1.72K ﹤0.01% 6144
2015
Q3
$74K Sell
1,228
-324
-21% -$19.5K ﹤0.01% 5559
2015
Q2
$121K Sell
1,552
-3,929
-72% -$306K ﹤0.01% 5486
2015
Q1
$371K Sell
5,481
-12,532
-70% -$848K ﹤0.01% 4842
2014
Q4
$1.67M Buy
18,013
+9,282
+106% +$861K ﹤0.01% 3717
2014
Q3
$919K Buy
8,731
+5,522
+172% +$581K ﹤0.01% 4107
2014
Q2
$460K Buy
3,209
+821
+34% +$118K ﹤0.01% 4642
2014
Q1
$361K Buy
2,388
+551
+30% +$83.3K ﹤0.01% 4772
2013
Q4
$337K Buy
1,837
+609
+50% +$112K ﹤0.01% 4741
2013
Q3
$272K Sell
1,228
-3,121
-72% -$691K ﹤0.01% 4720
2013
Q2
$760K Buy
+4,349
New +$760K ﹤0.01% 3941